• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症生物学中的三维组织培养模型

Three-dimensional tissue culture models in cancer biology.

作者信息

Kim Jong Bin

机构信息

Ludwig Institute for Cancer Research, First Floor - Breast Cancer Laboratory, Department of Surgery, Royal Free and University College London Medical School, Charles Bell House, 67-73 Riding House Street, London W1W 7EJ, UK.

出版信息

Semin Cancer Biol. 2005 Oct;15(5):365-77. doi: 10.1016/j.semcancer.2005.05.002.

DOI:10.1016/j.semcancer.2005.05.002
PMID:15975824
Abstract

Three-dimensional (3D) tissue culture models have an invaluable role in tumour biology today providing some very important insights into cancer biology. As well as increasing our understanding of homeostasis, cellular differentiation and tissue organization they provide a well defined environment for cancer research in contrast to the complex host environment of an in vivo model. Due to their enormous potential 3D tumour cultures are currently being exploited by many branches of biomedical science with therapeutically orientated studies becoming the major focus of research. Recent advances in 3D culture and tissue engineering techniques have enabled the development of more complex heterologous 3D tumour models.

摘要

三维(3D)组织培养模型在当今肿瘤生物学中发挥着不可估量的作用,为癌症生物学提供了一些非常重要的见解。除了增进我们对体内平衡、细胞分化和组织组织的理解外,与体内模型复杂的宿主环境相比,它们为癌症研究提供了一个明确界定的环境。由于其巨大的潜力,3D肿瘤培养目前正被生物医学科学的许多分支所利用,以治疗为导向的研究成为主要研究重点。3D培养和组织工程技术的最新进展使得更复杂的异源3D肿瘤模型得以开发。

相似文献

1
Three-dimensional tissue culture models in cancer biology.癌症生物学中的三维组织培养模型
Semin Cancer Biol. 2005 Oct;15(5):365-77. doi: 10.1016/j.semcancer.2005.05.002.
2
Three-dimensional in vitro tissue culture models of breast cancer-- a review.乳腺癌的三维体外组织培养模型——综述
Breast Cancer Res Treat. 2004 Jun;85(3):281-91. doi: 10.1023/B:BREA.0000025418.88785.2b.
3
Engineering tumors: a tissue engineering perspective in cancer biology.工程肿瘤:癌症生物学中的组织工程视角。
Tissue Eng Part B Rev. 2010 Jun;16(3):351-9. doi: 10.1089/ten.TEB.2009.0676.
4
Three-dimensional cell culture to model epithelia in the female reproductive system.用于模拟女性生殖系统上皮组织的三维细胞培养。
Reprod Sci. 2007 Dec;14(8 Suppl):11-9. doi: 10.1177/1933719107310872.
5
Can tissue engineering concepts advance tumor biology research?组织工程学概念能否推动肿瘤生物学研究?
Trends Biotechnol. 2010 Mar;28(3):125-33. doi: 10.1016/j.tibtech.2009.12.001. Epub 2010 Jan 6.
6
Three-dimensional culture using a radial flow bioreactor induces matrix metalloprotease 7-mediated EMT-like process in tumor cells via TGFbeta1/Smad pathway.使用径向流生物反应器进行的三维培养通过TGFβ1/Smad途径诱导肿瘤细胞中基质金属蛋白酶7介导的类上皮-间质转化过程。
Int J Oncol. 2009 May;34(5):1433-48.
7
Engineering tumors with 3D scaffolds.使用3D支架构建肿瘤模型
Nat Methods. 2007 Oct;4(10):855-60. doi: 10.1038/nmeth1085. Epub 2007 Sep 2.
8
Are micropatterned substrates for directed cell organization an effective method to create ordered 3D tissue constructs?用于定向细胞组织的微图案化基质是创建有序三维组织构建体的有效方法吗?
J Tissue Eng Regen Med. 2008 Oct;2(7):450-3. doi: 10.1002/term.114.
9
Living in three dimensions: 3D nanostructured environments for cell culture and regenerative medicine.三维空间中的生活:用于细胞培养和再生医学的3D纳米结构环境。
Cell Biochem Biophys. 2006;45(2):215-27. doi: 10.1385/CBB:45:2:215.
10
Death in the third dimension: apoptosis regulation and tissue architecture.三维空间中的死亡:细胞凋亡调控与组织结构
Curr Opin Genet Dev. 2004 Feb;14(1):71-80. doi: 10.1016/j.gde.2003.12.005.

引用本文的文献

1
Generation of Individualized, Standardized, and Electrically Synchronized Human Midbrain Organoids.个体化、标准化和电同步化人类中脑类器官的生成。
Cells. 2025 Aug 6;14(15):1211. doi: 10.3390/cells14151211.
2
Bioprintable and injectable TiO-loaded hydrogels for photothermal therapy of glioma.用于胶质瘤光热治疗的可生物打印和可注射的负载二氧化钛水凝胶
Mater Today Bio. 2025 May 12;32:101867. doi: 10.1016/j.mtbio.2025.101867. eCollection 2025 Jun.
3
Reducing the effective dosage of flutamide on prostate cancer cell lines through combination with selenium nanoparticles: An in-vitro study.
通过与硒纳米颗粒联合使用降低氟他胺对前列腺癌细胞系的有效剂量:一项体外研究。
PLoS One. 2025 May 19;20(5):e0318483. doi: 10.1371/journal.pone.0318483. eCollection 2025.
4
Development of a reliable method for human triple-negative breast cancer organotypic culture: Improving imaging and genomic studies in 3D cultures.人类三阴性乳腺癌类器官培养可靠方法的开发:改进三维培养中的成像和基因组研究。
J Tissue Eng. 2025 May 7;16:20417314251326668. doi: 10.1177/20417314251326668. eCollection 2025 Jan-Dec.
5
The Evolution of Anticancer 3D In Vitro Models: The Potential Role of Machine Learning and AI in the Next Generation of Animal-Free Experiments.抗癌3D体外模型的演变:机器学习和人工智能在下一代无动物实验中的潜在作用。
Cancers (Basel). 2025 Feb 19;17(4):700. doi: 10.3390/cancers17040700.
6
SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.SMARCA4通过抑制RHOA抑制乳腺癌进展和转移。
Cancer Res. 2025 May 15;85(10):1803-1818. doi: 10.1158/0008-5472.CAN-24-2801.
7
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicity.CD64/CD28/CD3ζ嵌合受体可重编程T细胞代谢,促进T细胞持久性和免疫功能,同时引发非抗体依赖性和抗体依赖性细胞毒性。
Exp Hematol Oncol. 2025 Feb 17;14(1):17. doi: 10.1186/s40164-025-00601-2.
8
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids.通过患者来源的类器官探索肠道微生物群对胆管癌进展的影响。
J Transl Med. 2025 Jan 9;23(1):34. doi: 10.1186/s12967-024-06012-x.
9
Application of Single Cell Type-Derived Spheroids Generated by Using a Hanging Drop Culture Technique in Various Disease Models: A Narrow Review.利用悬滴培养技术生成的单细胞来源球体在各种疾病模型中的应用:一个简要综述。
Cells. 2024 Sep 14;13(18):1549. doi: 10.3390/cells13181549.
10
An Open-Source 3D-Printed Recording Stage with Customizable Chambers for Ex Vivo Experiments.一种开源的 3D 打印记录平台,带有可定制的腔室,用于离体实验。
eNeuro. 2024 Sep 13;11(9). doi: 10.1523/ENEURO.0257-24.2024. Print 2024 Sep.